T Christodoulides1, R Dudley, S Brown, D Turkington, Aaron T Beck. 1. South of Tyne Early Intervention in Psychosis Service, Northumberland, Tyne and Wear Mental Health NHS Trust, Sunderland, UK. tom.christodoulides@stw.nhs.uk
Abstract
OBJECTIVES:Cognitive behaviour therapy (CBT) as an adjunct to medication has been shown to improve symptom management in patients with schizophrenia. However, little is understood about the value of CBT for people who are not prescribed antipsychotic medication. DESIGN: A post hoc case series design was used to examine the outcome data of three participants selected from a randomized controlled trial for CBT for schizophrenia. The participants were included if they had received CBT and were not prescribed antipsychotic medication during active treatment. RESULTS: The three patients improved on outcome measures of psychopathology, depression, or negative symptoms, some to a clinically significant degree. CONCLUSIONS:CBT is a feasible treatment for people with schizophrenia who are not prescribed antipsychotic medication. It may be a valuable alternative to medication in treating symptoms of schizophrenia.
RCT Entities:
OBJECTIVES: Cognitive behaviour therapy (CBT) as an adjunct to medication has been shown to improve symptom management in patients with schizophrenia. However, little is understood about the value of CBT for people who are not prescribed antipsychotic medication. DESIGN: A post hoc case series design was used to examine the outcome data of three participants selected from a randomized controlled trial for CBT for schizophrenia. The participants were included if they had received CBT and were not prescribed antipsychotic medication during active treatment. RESULTS: The three patients improved on outcome measures of psychopathology, depression, or negative symptoms, some to a clinically significant degree. CONCLUSIONS: CBT is a feasible treatment for people with schizophrenia who are not prescribed antipsychotic medication. It may be a valuable alternative to medication in treating symptoms of schizophrenia.